From: Cancer incidence in Germany attributable to human papillomavirus in 2013
Cancer site | Incident cases independent of morphology | Incident cases of HPV-associated morphology | (Proportion estimated)a | HPV-attributable fraction PAF | Reference | Estimated HPV-attributable incident cases | (Proportion of overall anogenital and oropharyngeal cancer) |
---|---|---|---|---|---|---|---|
Cervix | 4458 | 4422 | (7.1%) | 100% | [1] | 4422 | (70.9%) |
Vulva | 3015 | 2596 | (4.0%) | 18% | [11] | 467 | (7.5%) |
Vagina | 386 | 275 | (9.6%) | 81% | [13] | 223 | (3.6%) |
Female anus | 1142 | 1030 | (5.0%) | 90% | [14] | 927 | (14.9%) |
Female oropharynx | 1371 | 1249 | (7.5%) | 16% | [15] | 200 | (3.2%) |
Female overall anogenital & oropharynx | 10,372 | 9573 | (6.1%) | Â | Â | 6239 | (100%) |
Penis | 757 | 704 | (6.3%) | 32% | [12] | 225 | (16.6%) |
Male anus | 653 | 564 | (3.9%) | 88% | [14] | 496 | (36.5%) |
Male oropharynx | 4154 | 3978 | (5.8%) | 16% | [15] | 636 | (46.9%) |
Male overall anogenital & oropharynx | 5564 | 5246 | (5.7%) | Â | Â | 1358 | (100%) |